{"schema_version":"secwatch.filing_event.v1","accession":"0001274737-24-000019","form_type":"8-K","ticker":"XGN","cik":"0001274737","company_name":"EXAGEN INC.","filed_at":"2024-03-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.648286+00:00","generated_at":"2026-06-04T14:35:51.796143+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Exagen reports record FY2023 revenue of $52.5M; net loss narrows to $23.7M","bullets":["Record full-year revenue $52.5M (+10% YoY); Q4 revenue $13.8M (+8% YoY)","Record 137,650 AVISE CTD tests performed in 2023; trailing 12-month ASP rose to $336","Gross margin improved to 56% for FY2023 (59% Q4) from 44% in FY2022","Net loss $23.7M for FY2023 vs $35.1M in FY2022; adjusted EBITDA -$17.1M vs -$29.1M","Cash balance $36.5M at year-end; management cites progress toward profitability"],"urls":{"canonical":"https://secwatch.observer/filing/0001274737-24-000019","json":"https://secwatch.observer/filing/0001274737-24-000019.json","markdown":"https://secwatch.observer/filing/0001274737-24-000019.md","text":"https://secwatch.observer/filing/0001274737-24-000019.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1274737/000127473724000019/0001274737-24-000019-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1274737/000127473724000019/exdx-20240318.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T14:35:51.796143+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"778143415f9b748d193baa98dc031fc134958ad1","claim":"EXAGEN INC. reported the quarter and year ended December 31, 2023 results: revenue $13.8 million for the fourth quarter of 2023, net income $5.6 million for the fourth quarter of 2023.","evidence_excerpt":"On March 18, 2024 , the Company reported its financial results for the quarter and year ended December 31, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1274737/000127473724000019/0001274737-24-000019-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter and year ended December 31, 2023"},{"label":"Revenue","value":"$13.8 million for the fourth quarter of 2023"},{"label":"Net income","value":"$5.6 million for the fourth quarter of 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}